DGX vs. LH: Quest Diagnostics vs. Labcorp Stock Comparison
How do Quest Diagnostics (DGX) and Labcorp (LH) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Quest Diagnostics (DGX) and Labcorp (LH) are both classified in the Health Care Services sub-industry within the broader Health Care Providers & Services industry, placing them in the closest GICS peer bucket.
| Profile Item | DGX | LH |
|---|---|---|
| Name | Quest Diagnostics Incorporated | Labcorp Holdings Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Providers & Services | Health Care Providers & Services |
| GICS Sub-Industry | Health Care Services | Health Care Services |
| Market Capitalization | 28.21 billion USD | 29.77 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | December 17, 1996 | March 29, 1990 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | DGX | LH |
|---|---|---|
| Total Return (1Y) | 45.88% | 48.62% |
| Total Return (3Y, Annualized) | 27.45% | 23.39% |
| Total Return (5Y, Annualized) | 14.84% | 10.54% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | DGX | LH |
|---|---|---|
| Volatility (1Y, Annualized) | 24.06% | 24.36% |
| Beta (5Y) | 0.54 | 0.85 |
| Max Drawdown (5Y) | -28.62% | -34.61% |
| Avg. Volume (3M) | 1.00M | 721.05K |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | DGX | LH |
|---|---|---|
| Sharpe Ratio (1Y) | 1.73 | 1.82 |
| Sortino Ratio (1Y) | 3.16 | 2.99 |
Profitability
ROE (TTM)
Quest Diagnostics (DGX) at 15.32% sits in the top ROE quartile, while Labcorp (LH) at 11.44% is closer to the peer norm — stronger capital efficiency for DGX.
DGX
Health Care Equipment & Services industry group
15.32%
- Max
- 47.61%
- DGX
- 15.32%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
LH
Health Care Equipment & Services industry group
11.44%
- Max
- 47.61%
- Q3
- 14.36%
- LH
- 11.44%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
Quest Diagnostics (DGX) at 9.54% retains a top-quartile share of revenue as profit, ahead of Labcorp (LH) at 6.88%, which keeps about the industry-typical share.
DGX
Health Care Equipment & Services industry group
9.54%
- Max
- 29.35%
- DGX
- 9.54%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
LH
Health Care Equipment & Services industry group
6.88%
- Max
- 29.35%
- Q3
- 9.33%
- LH
- 6.88%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Quest Diagnostics (DGX) at 15.63% operates in the top operating margin quartile, ahead of Labcorp (LH) at 10.91%, which runs around its industry’s norm.
DGX
Health Care Equipment & Services industry group
15.63%
- Max
- 35.43%
- DGX
- 15.63%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
LH
Health Care Equipment & Services industry group
10.91%
- Max
- 35.43%
- Q3
- 14.14%
- LH
- 10.91%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | DGX | LH |
|---|---|---|
| ROE (TTM) | 15.32% | 11.44% |
| ROA (TTM) | 6.61% | 5.48% |
| Net Margin (TTM) | 9.54% | 6.88% |
| Operating Margin (TTM) | 15.63% | 10.91% |
| Gross Margin (TTM) | 33.18% | 28.96% |
Growth
Revenue Growth
Both Quest Diagnostics (DGX) at 11.78% and Labcorp (LH) at 7.25% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Both Quest Diagnostics (DGX) at 13.78% and Labcorp (LH) at 18.33% land near their industries' usual EPS growth ranges, so bottom-line momentum looks broadly in line with peers on both sides.
Growth Metrics
| Metric | DGX | LH |
|---|---|---|
| Revenue Growth (YoY) | 11.78% | 7.25% |
| Revenue Growth (3Y CAGR) | 3.74% | 5.55% |
| EPS Growth (YoY) | 13.78% | 18.33% |
| EPS Growth (3Y CAGR) | 3.16% | -9.19% |
Financial Strength
Current Ratio (MRQ)
Both Quest Diagnostics (DGX) at 1.70 and Labcorp (LH) at 1.41 carry current ratio within their industries’ typical mid-ranges, suggesting balanced short-term liquidity relative to peers.
DGX
Health Care Equipment & Services industry group
1.70
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- DGX
- 1.70
- Q1
- 1.37
- Min
- 0.30
LH
Health Care Equipment & Services industry group
1.41
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- LH
- 1.41
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Both Quest Diagnostics (DGX) at 0.80 and Labcorp (LH) at 0.77 fund their balance sheets with roughly industry-typical debt-to-equity mixes.
DGX
Health Care Equipment & Services industry group
0.80
- Max
- 1.88
- Q3
- 0.91
- DGX
- 0.80
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
LH
Health Care Equipment & Services industry group
0.77
- Max
- 1.88
- Q3
- 0.91
- LH
- 0.77
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | DGX | LH |
|---|---|---|
| Current Ratio (MRQ) | 1.70 | 1.41 |
| Debt / Equity (MRQ) | 0.80 | 0.77 |
| Net Debt / EBITDA | 2.38 | 2.81 |
Dividends
Dividend Yield (TTM)
Both Quest Diagnostics (DGX) at 1.33% and Labcorp (LH) at 0.79% yield above their industries’ entire benchmark ranges — high enough that dividend safety, not income, becomes the first question.
DGX
Health Care Equipment & Services industry group
1.33%
- DGX
- 1.33%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LH
Health Care Equipment & Services industry group
0.79%
- LH
- 0.79%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Both Quest Diagnostics (DGX) at 25.10% and Labcorp (LH) at 23.61% pay out more of their earnings than any of their industry peers — the thinnest cover in their groups, so dividend headroom deserves attention.
DGX
Health Care Equipment & Services industry group
25.10%
- DGX
- 25.10%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
LH
Health Care Equipment & Services industry group
23.61%
- LH
- 23.61%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | DGX | LH |
|---|---|---|
| Dividend Yield (TTM) | 1.33% | 0.79% |
| Dividend Payout Ratio (TTM) | 25.10% | 23.61% |
Valuation
P/E Ratio (TTM)
Both Quest Diagnostics (DGX) at 25.46 and Labcorp (LH) at 30.05 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.
DGX
Health Care Equipment & Services industry group
25.46
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- DGX
- 25.46
- Q1
- 21.19
- Min
- 4.21
LH
Health Care Equipment & Services industry group
30.05
- Max
- 80.41
- Q3
- 47.62
- LH
- 30.05
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
On P/S ratio, both Quest Diagnostics (DGX) at 2.38 and Labcorp (LH) at 2.04 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.
DGX
Health Care Equipment & Services industry group
2.38
- Max
- 8.80
- Q3
- 4.32
- DGX
- 2.38
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
LH
Health Care Equipment & Services industry group
2.04
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- LH
- 2.04
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
On P/B ratio, both Quest Diagnostics (DGX) at 3.68 and Labcorp (LH) at 3.36 are valued close to their industries’ norm against book — neither stands out from peers.
DGX
Health Care Equipment & Services industry group
3.68
- Max
- 11.68
- Q3
- 6.12
- DGX
- 3.68
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
LH
Health Care Equipment & Services industry group
3.36
- Max
- 11.68
- Q3
- 6.12
- LH
- 3.36
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | DGX | LH |
|---|---|---|
| P/E Ratio (TTM) | 25.46 | 30.05 |
| P/S Ratio (TTM) | 2.38 | 2.04 |
| P/B Ratio (MRQ) | 3.68 | 3.36 |
| Free Cash Flow Yield (TTM) | 3.09% | 3.55% |